» Articles » PMID: 25176415

Severe Phenotype in an Apparent Homozygosity Caused by a Large Deletion in the CFTR Gene: a Case Report

Abstract

Background: Over 1900 mutations have been identified in the cystic fibrosis conductance transmembrane regulator gene, including single nucleotide substitutions, insertions, and deletions. Unidentified mutations may still lie in introns or in regulatory regions, which are not routinely investigated, or in large genomic deletions, which are not revealed by conventional molecular analysis. The apparent homozygosity for a rare, cystic fibrosis conductance transmembrane regulator mutation screened by standard molecular analysis should be further investigated to confirm if the mutation is in fact homozygous. We describe a patient presenting with an apparent homozygous S4X mutation.

Case Presentation: A 13-year-old female patient of African descent with clinical symptoms of classic cystic fibrosis and a positive sweat test (97 mEq/L, diagnosed at age 3 years) presented with pancreatic insufficiency and severe pulmonary symptoms (initial lung colonization with Pseudomonas aeruginosa at age 4 years; forced vital capacity: 69%; forced expiratory volume: 51%; 2011). Furthermore, she developed severe acute lung disease and recurrent episodes of dehydration requiring hospitalization. The girl carried the CFTR mutation S4X in apparent homozygosity. However, further analysis revealed a large deletion in the second allele that included the region of the mutation. The deletion that we describe includes nucleotides 120-142, which correspond to a loss of 23 nucleotides that abolishes the normal translation initiation codon.

Conclusion: This study reiterates the view that large, cystic fibrosis conductance transmembrane regulator deletions are an important cause of severe cystic fibrosis and emphasizes the importance of including large deletions/duplications in cystic fibrosis conductance transmembrane regulator diagnostic tests.

Citing Articles

Interpretation of Autosomal Recessive Kidney Diseases With "Presumed Homozygous" Pathogenic Variants Should Consider Technical Pitfalls.

Deng H, Zhang Y, Yao Y, Xiao H, Su B, Xu K Front Pediatr. 2020; 8:165.

PMID: 32363171 PMC: 7180205. DOI: 10.3389/fped.2020.00165.


A comprehensive overview of the cystic fibrosis on the island of São Miguel (Azores, Portugal).

Rosa J, Gaspar-Silva P, Pacheco P, Silva C, Branco C, Vieira B BMC Pediatr. 2020; 20(1):2.

PMID: 31900120 PMC: 6942372. DOI: 10.1186/s12887-019-1903-y.


Identification and Characterization of New Mutations Associated With PEO Syndrome and Multiple Mitochondrial DNA Deletions.

Carreno-Gago L, Blazquez-Bermejo C, Diaz-Manera J, Camara Y, Gallardo E, Marti R Front Genet. 2019; 10:576.

PMID: 31258551 PMC: 6588129. DOI: 10.3389/fgene.2019.00576.


Identification of a novel large deletion and other copy number variations in the CFTR gene in patients with Cystic Fibrosis from a multiethnic population.

Martins R, Junior M, Moreira A, Zembrzuski V, Proenca da Fonseca A, Abreu G Mol Genet Genomic Med. 2019; 7(7):e00645.

PMID: 31199594 PMC: 6625342. DOI: 10.1002/mgg3.645.


Differences in gene mutations between Chinese and Caucasian cystic fibrosis patients.

Zheng B, Cao L Pediatr Pulmonol. 2016; 52(3):E11-E14.

PMID: 27717243 PMC: 5324682. DOI: 10.1002/ppul.23539.

References
1.
Ramalho A, Lewandowska M, Farinha C, Mendes F, Goncalves J, Barreto C . Deletion of CFTR translation start site reveals functional isoforms of the protein in CF patients. Cell Physiol Biochem. 2009; 24(5-6):335-46. PMC: 2793277. DOI: 10.1159/000257426. View

2.
Streit C, Burlamaque-Neto A, de Abreu e Silva F, Giugliani R, Pereira M . CFTR gene: molecular analysis in patients from South Brazil. Mol Genet Metab. 2003; 78(4):259-64. DOI: 10.1016/s1096-7192(03)00033-7. View

3.
Raskin S, Phillips 3rd J, Krishnamani M, Parker R, Rozov T, Cardieri J . DNA analysis of cystic fibrosis in Brazil by direct PCR amplification from Guthrie cards. Am J Med Genet. 1993; 46(6):665-9. DOI: 10.1002/ajmg.1320460612. View

4.
. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med. 1993; 329(18):1308-13. DOI: 10.1056/NEJM199310283291804. View

5.
Estivill X, Bancells C, Ramos C . Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat. 1997; 10(2):135-54. DOI: 10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.0.CO;2-J. View